Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:06 PM ET 10-Q
Financial Results Flux Power Holdings, Inc. FLUX ▶ Call

Flux Power Holdings Q1 2026 Results: Net Loss of $3.2M, Loss Widens

Flux Power reported a significant revenue decline to $6.8M for the quarter ended September 30, 2026, compared to $13.2M in the prior year, leading to a net loss of $3.2M. The company highlighted substantial risks including an event of default under its credit facility with Gibraltar Business Capital and concerns regarding its ability to continue as a going concern.

Key figure
Net loss $3.2M
4:06 PM ET 10-Q
Financial Results Calix, Inc CALX ▶ Call

Calix Q3 2026 Results: Net Income $10.2M, Down 34.7% YoY

Calix, Inc. reported total revenue of $301.7 million for the third quarter of 2026, a 13.7% increase year-over-year, driven by growth in both appliance and software/service segments. Net income for the nine months ended September 26, 2026, rose significantly to $38.5 million compared to $10.7 million in the prior year, despite a substantial $290.2 million cash outflow for common stock repurchases.

Key figure
Net income $10.2M · -34.7% YoY
4:06 PM ET 8-K
Leadership Change Concord Acquisition Corp II CNDA

Concord Acquisition Corp II Leadership Change

Michele Cito resigned as Chief Financial Officer of Concord Acquisition Corp II effective October 28, 2026. The board appointed Charles Coop, currently Vice President of Finance at Atlas Merchant Capital LLC, to succeed her as CFO on the same date.

4:06 PM ET 8-K
Investor Presentation Peoples Bancorp Inc PEBO

Peoples Bancorp Investor Presentation

Peoples Bancorp Inc. management, including the CEO and CFO, will conduct meetings with investors and analysts between November 3 and December 31, 2026. The company filed its 3rd Quarter 2026 Investor Presentation as an exhibit to assist with the understanding of its business and financial performance.

4:06 PM ET 8-K
Financial Results Amgen Inc AMGN

Amgen Financial Results

Amgen reported third quarter 2026 financial results with total revenues increasing 8% year-over-year to $10.4 billion, driven by volume growth across its commercial portfolio. GAAP EPS rose 19% to $7.08, while the company generated $3.7 billion in free cash flow during the period.

Term
Q3 2026

“Amgen delivered another strong quarter as our strategy for long-term growth continued to produce results across the enterprise. The strength of our commercial portfolio, combined with important clinical advances and a promising late-stage pipeline, reinforces our confidence in Amgen’s ability to deliver durable growth well into the next decade.”

Robert A. Bradway, chairman and chief executive officer
4:06 PM ET 8-K
Financial Results Angi Inc. ANGI

Angi Financial Results

Angi Inc. reported Q3 2026 financial results with revenue of $242.0 million, a 9% year-over-year decrease, and net earnings of $1.3 million. The company also announced a workforce reduction of approximately 300 roles aimed at generating $50-$60 million in annual run-rate savings to improve organizational velocity and profitability.

Term
Q3 2026

“Angi has one of the most recognized brands in home services, a large network of Pros and an enormous market opportunity. My first 45 days have reinforced my conviction in the potential of this business. We're building on the work already underway to simplify how we operate, move faster and develop better products using technology and AI. I see significant opportunities to improve profitability and cash flow in the near term while building a stronger company positioned for long-term growth.”

Mike Steib, Chief Executive Officer of Angi
4:06 PM ET Form 4
Insider Selling Artiva Biotherapeutics, Inc. ARTV

Artiva Biotherapeutics Chief Tech Operations Officer Christopher Horan Sells $43.6K of Stock

Christopher Horan, Chief Tech Operations Officer, sold 10,423 shares of Artiva Biotherapeutics, Inc. at $4.18 a share, worth $43.6K in total on Nov 2, 2026. Shares held after the trade: 302,321 (-3.3%).

Value
$43.6K
Shares
10,423
Price
$4.18
Role
Chief Tech Operations Officer
Holding change
-3.3%
Trade date
Nov 2, 2026
4:06 PM ET Form 4
Insider Selling Extreme Networks Inc EXTR

Extreme Networks President and CEO Edward Meyercord Sells $1.13M of Stock

Edward Meyercord, President and CEO, sold 50,000 shares of Extreme Networks Inc at $22.57 a share, worth $1.13M in total on Nov 2, 2026. Shares held after the trade: 1,660,097 (-2.9%).

Value
$1.13M
Shares
50,000
Price
$22.57
Role
President and CEO
Holding change
-2.9%
Trade date
Nov 2, 2026
4:06 PM ET 8-K
Shareholder Meeting Scienture Holdings, Inc. SCNX

Scienture Holdings Shareholder Meeting

Scienture Holdings held its 2026 Annual Meeting of Stockholders on October 28, 2026, where shareholders voted on four key proposals. Stockholders elected five directors to the board, ratified CM3 Advisory as the independent auditor for fiscal year 2026, and approved executive compensation on a non-binding advisory basis.

4:06 PM ET 8-K
Financial Results Ssr Mining Inc. SSRM

Ssr Mining Financial Results

SSR Mining reported Q3 2026 net income of $94.8 million and adjusted net income of $130.7 million, driven by production of 103,585 gold equivalent ounces. The company maintained its full-year production guidance but noted that AISC is expected to trend 10% above the original guidance range due to inflation and mine resequencing. SSR Mining also declared a quarterly dividend of $0.03 per share and highlighted its strategic repositioning to an Americas-focused producer following the sale of its Hod Maden stake.

Term
Q3 2026
4:06 PM ET 10-Q
Financial Results Stoke Therapeutics, Inc. STOK

Stoke Therapeutics Q3 2026 Results: Net Loss of $73.6M, Loss Widens

For the nine months ended September 30, 2026, Stoke Therapeutics reported a net loss of $185.3 million, a significant reversal from a net income of $51.0 million in the prior year period, primarily due to a sharp decrease in revenue from $183.0 million to $26.8 million. Operating expenses rose substantially, with research and development costs increasing by 55% to $149.0 million as the company advances its clinical programs for zorevunersen.

Key figure
Net loss $73.6M
4:06 PM ET 8-K
Loan & Debt Ocean Power Technologies, Inc. OPTT

Ocean Power Technologies Debt Financing Update with Vanquish Funding Group Inc.

Ocean Power Technologies entered into a Securities Purchase Agreement with Vanquish Funding Group for a 12% promissory note in the principal amount of $373,750. The agreement includes potential additional tranches of financing up to $2.875 million over the next twelve months and allows for conversion into common stock only upon an event of default.

Counterparty
Vanquish Funding Group Inc.
Term
through Oct 2027
4:06 PM ET 8-K
Loan & Debt BWX Technologies, Inc. BWXT

BWX Technologies $1.25B Debt Financing with Wells Fargo Bank, National Association

BWX Technologies entered into an amendment to its existing credit agreement to extend the maturity of its $1.25 billion senior secured revolving credit facility by one year to November 10, 2031. The amendment also modifies the minimum interest coverage ratio requirements and introduces a new pricing grid tied to the company's corporate credit ratings.

Value
$1.25B
Counterparty
Wells Fargo Bank, National Association
Term
through Nov 2031
4:06 PM ET 10-Q
Financial Results SLR Private Credit BDC II LLC

SLR Private Credit BDC II Q3 2026 Results: Net Income $393K, Up 12.0% YoY

For the nine months ended September 30, 2026, SLR Private Credit BDC II LLC reported total investment income of $3.79 million and net investment income of $1.49 million. The company's net asset value per unit increased to $16.37 from $16.01 at the end of 2025, while total unitholders' capital grew to $19.54 million despite $0.8 million in distributions.

Key figure
Net income $393K · +12.0% YoY
4:06 PM ET 10-Q
Financial Results Ardelyx, Inc. ARDX

Ardelyx Q3 2026 Results: Net Loss of $737K, Loss Narrows

For the nine months ended September 30, 2026, Ardelyx reported total revenues of $343.0 million, a significant increase from $282.1 million in the prior year period, driven primarily by net product sales of IBSRELA and XPHOZAH. Despite the revenue growth, the company recorded a net loss of $55.1 million for the first nine months of 2026, though this was an improvement over the $61.2 million net loss in the same period of 2025.

Key figure
Net loss $737K
4:06 PM ET 8-K
Dividend PennantPark Floating Rate Capital Ltd. PFLT

PennantPark Floating Rate Capital Dividend

PennantPark Floating Rate Capital Ltd. declared a monthly distribution for November 2026 of $0.0833 per share. The distribution consists of an $0.08 base dividend and a $0.0033 supplemental dividend, payable on December 1, 2026, to stockholders of record as of November 13, 2026.

4:06 PM ET Form 4
Insider Selling Nextera Energy Inc NEE

Nextera Energy EVP, Finance & CFO Michael Dunne Sells $585K of Stock

Michael Dunne, EVP, Finance & CFO, sold 6,888 shares of Nextera Energy Inc at $85.00 a share, worth $585K in total on Nov 2, 2026. Shares held after the trade: 64,063 (-9.7%).

Value
$585K
Shares
6,888
Price
$85.00
Role
EVP, Finance & CFO
Holding change
-9.7%
Trade date
Nov 2, 2026
4:06 PM ET 10-Q
Financial Results SCP Private Credit Income BDC LLC

SCP Private Credit Income BDC Q3 2026 Results: Net Income $2.9M, Down 30.4% YoY

SCP Private Credit Income BDC LLC reported a net increase in unitholders' capital resulting from operations of $2.6 million for the nine months ended September 30, 2026, down from $7.0 million in the prior year period. The company's net asset value per unit decreased to $9.01 from $9.42 at the end of 2025, primarily driven by net unrealized losses on investments and distributions to unitholders.

Key figure
Net income $2.9M · -30.4% YoY
4:06 PM ET 8-K
Partnership Profound Medical Corp. PROF

Profound Medical Partnership with Cook Medical Holdings LLC

Profound Medical entered into a supply and distribution agreement with Cook Medical to appoint them as a non-exclusive distributor of the TULSA-PRO system in the U.S. The partnership integrates TULSA-PRO into Cook's Copernicus program for intraoperative MRI suites, expanding Profound's sales channels while retaining direct recurring revenue from disposables and service.

Counterparty
Cook Medical Holdings LLC
Term
5 years
4:06 PM ET 8-K
Loan & Debt Fathom Holdings Inc. FTHM

Fathom Holdings Debt Financing Update with two accredited investors

Fathom Holdings entered into a Third Omnibus Amendment to its Senior Secured Convertible Promissory Notes, extending the maturity date from November 1, 2026, to November 30, 2026. The amendment defers all accrued and unpaid interest until the new maturity date and introduces a weekly extension fee of 0.5% of the outstanding principal amount.

Counterparty
two accredited investors
Term
through Nov 30, 2026
4:06 PM ET 10-Q
Financial Results Slr Hc BDC LLC

Slr Hc BDC Q3 2026 Results: Net Income $761K, Up 24.3% YoY

For the nine months ended September 30, 2026, SLR HC BDC LLC reported total investment income of $7.1 million and net investment income of $3.1 million. The company's net asset value per unit decreased slightly to $20.87 from $21.11 at the end of 2025, while total unitholders' capital grew to $60.7 million due to $16.7 million in capital contributions.

Key figure
Net income $761K · +24.3% YoY
4:06 PM ET 8-K
Financial Results RxSight, Inc. RXST

RxSight Financial Results

RxSight reported Q3 2026 revenue of $24.6 million, a 19% decrease year-over-year, primarily due to competitive pressures. The company highlighted a strengthened commercial leadership team and a $60 million cash infusion from its strategic collaboration with Alcon, ending the quarter with $254.7 million in cash and investments.

Term
3 months

“Since I joined last quarter, the team has moved quickly and accomplished a great deal in a short period of time. We have strengthened our commercial organization and leadership, made progress across key long-term growth initiatives, and taken decisive actions to align our cost structure with our priorities. While there is more work ahead, we remain focused on execution. Based on our progress, I am confident we are positioning our company for long-term success.”

Aziz Mottiwala, President and Chief Executive Officer
4:06 PM ET 8-K
Financial Results Sixth Street Specialty Lending, Inc. TSLX

Sixth Street Specialty Lending Financial Results

Sixth Street Specialty Lending reported third quarter 2026 financial results with net investment income of $0.44 per share and a net asset value of $16.19 per share. The company also declared a fourth quarter base dividend of $0.42 per share and a third quarter supplemental dividend of $0.01 per share.

“Our objective is not to compete for the same investments on the same terms, but to bring a differentiated perspective to where and how we invest capital. We believe these capabilities position us well to navigate an increasingly bifurcated market and compound long-term value for our shareholders.”

Bo Stanley, Chief Executive Officer
4:06 PM ET Form 4
Insider Selling Artiva Biotherapeutics, Inc. ARTV

Artiva Biotherapeutics COO, CLO, Compliance Officer Jennifer Bush Sells $35.3K of Stock

Jennifer Bush, COO, CLO, Compliance Officer, sold 8,439 shares of Artiva Biotherapeutics, Inc. at $4.18 a share, worth $35.3K in total on Nov 2, 2026. Shares held after the trade: 357,720 (-2.3%).

Value
$35.3K
Shares
8,439
Price
$4.18
Role
COO, CLO, Compliance Officer
Holding change
-2.3%
Trade date
Nov 2, 2026
4:06 PM ET 8-K
Dividend Pennantpark Investment Corp PNNT

Pennantpark Investment Dividend

PennantPark Investment Corporation declared a monthly distribution for November 2026 of $0.08 per share. The distribution consists of a $0.04 base dividend and a $0.04 supplemental dividend, payable on December 1, 2026, to stockholders of record as of November 13, 2026.

4:06 PM ET 8-K
Shareholder Meeting Regis Corp RGS

Regis Shareholder Meeting

Regis Corporation held its 2026 Annual Meeting where five of six director nominees failed to receive a majority of votes cast, triggering conditional resignation offers under the company's majority voting policy. Shareholders also voted against the advisory 'say-on-pay' proposal regarding executive compensation, while ratifying Grant Thornton LLP as the independent auditor. Separately, the company announced that Jamie Suarez, EVP of Company Operations, will depart the company effective October 30, 2026.

4:06 PM ET 8-K
Leadership Change Erie Indemnity Co ERIE

Erie Indemnity Leadership Change

Timothy G. NeCastro retired as President and CEO effective November 2, 2026, which was an acceleration of his previously announced retirement date. Brian W. Bolash, the company's Executive Vice President, has been appointed Interim President and CEO effective November 3, 2026, while the board continues its search for a permanent successor.

4:06 PM ET 8-K
Dividend Weyco Group Inc WEYS

Weyco Group Dividend

Weyco Group's Board of Directors declared a special cash dividend of $2.00 per share, representing a total cash outlay of approximately $19 million. The dividend is payable on January 8, 2027, to shareholders of record as of November 17, 2026, and is being funded by excess cash on the company's balance sheet.

4:06 PM ET 8-K
M&A Deal Marinemax Inc HZO

Marinemax M&A Deal with Safe Harbor Marinas, LLC

MarineMax announced that all regulatory approvals and clearances have been obtained for its pending merger with affiliates of Safe Harbor Marinas (a Blackstone portfolio company). The company expects the transaction to close by the end of 2026, subject to a shareholder vote scheduled for November 11, 2026.

Counterparty
Safe Harbor Marinas, LLC
4:05 PM ET 8-K12B/A
M&A Deal Real Remax Group Inc. REAX

Real Remax Group M&A Deal with RE/MAX Holdings, Inc.

Real REMAX Group Inc. filed an amendment to its 8-K to provide historical and pro forma financial statements following its completed acquisition of RE/MAX Holdings, Inc. and The Real Brokerage Inc. The transaction, which closed on August 24, 2026, was accounted for as a business combination with Real as the accounting acquiror. The filing also details a $550 million term loan facility and a $40 million revolving credit facility used to finance the combination.

Counterparty
RE/MAX Holdings, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.